NAT10 and prostate carcinoma: BPH, benign prostatic hyperplasia; IPC, incidental prostate cancer; PSA, prostate-specific antigen; NLR, neutrophil-to-lymphocyte ratio; HALP, hemoglobin-albumin-lymphocyte-platelet